• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Paragonix Reveals Nationwide Organ Procurement Network

    Covalon Technologies Appoints Interim CEO

    GE HealthCare's Pneumothorax Algorithm Earns FDA Nod

    Viz.ai Accelerating Clinical Trial Recruitment for Heart Failure

    Apyx Welcomes Matthew Hill as Finance Chief
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Qosina Corp.

    Cirtec Medical

    Halkey-Roberts Corporation

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA

    2023 in Review: Philips Breathes No Easier in Respiratory Recall

    2023 in Review: The Legacy of Elizabeth Holmes

    2023 in Review: A Clean Start for EtO
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Qosina Corp.

    Cirtec Medical

    Halkey-Roberts Corporation

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    CARMAT Celebrates First Aeson Artificial Heart Commercial Implant

    Represents first CARMAT sale, paves the way for the company’s commercial development.

    Business Wire07.20.21
    CARMAT, designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, announced the first implant of its Aeson bioprosthetic artificial heart in a commercial setting.
     
    This implant of the Aeson artificial heart was performed by the team headed by heart surgeon Dr. Ciro Maiello at the Azienda Ospedaliera dei Colli hospital in Naples, one of the hospitals with the greatest experience in the field of artificial hearts in Italy.
     
    This implant represents the first sale ever recorded by CARMAT since it was created in 2008. It is a major milestone that opens-up a new chapter in the company’s development.
     
    In accordance with its strategy, in 2021, CARMAT intends to focus its Aeson artificial heart marketing efforts on Germany, and address one or two other EU countries, including Italy, in a more opportunistic way.
     
    Since it obtained CE marking for its artificial heart as a bridge to transplant in December 2020, the Company has initiated very active and constructive talks, from a scientific and medical as well as contractual perspectives, notably with the twenty most active German hospitals in the field of mechanical assistance.
     
    These discussions have confirmed both the extent of the patient population which could benefit from the Aeson heart and the medical community’s keen interest in a therapy understood to be truly innovative and providing patients with unique benefits.
     
    This assessment has been confirmed by the cardiac surgery teams at Duke University Hospital in the United States, who recently estimated1 the number of new cases of heart failure in that country at 100,000 per year, with only 3,000 to 4,000 of these patients currently able to benefit from a heart transplant, concluding that a substantial portion of the remaining 96,000 patients could potentially benefit from CARMAT’s solution.
     
    At this stage, 5 German hospitals have already been trained by CARMAT and are currently screening patients for an implant. A number of patient files are currently being analyzed by these hospitals with the support of CARMAT, whose teams will remain mobilized throughout the summer to ensure the continuity of the commercial launch of the Aeson artificial heart.

    The company expects around a dozen medical centers to be trained and commercially active by the end of 2021, primarily in Germany.
     
    CARMAT will provide a comprehensive update on its schedule and main strategic objectives when it publishes its half-year results on September 15, 2021.
     
    The terms of this communication will be specified at a later date.
     
    Prof. Marisa De Feo, Director of the Department of General Cardiac Surgery and Transplantation at Azienda Ospedaliera dei Colli, declared: “We are pleased to be the first center in the world to implant the Aeson total artificial heart in a commercial setting. The surgery has been performed by Dr. Ciro Maiello and Dr. Cristiano Amarelli without any particular difficulty thanks to the excellent preparation and cooperation between our department and the specialists from CARMAT. The patient is recovering well and, thanks to the combination of the main features of the device—pulsatility, hemocompatibility and self regulation—we believe that he will experience a rapid transition to outpatient management. I would also like to take the opportunity to thank the entire Department of Cardiac Surgery and the Azienda Ospedaliera dei Colli for continuing innovating in the domain of transplantation and mechanical assistance, and the Campania Region for supporting our program.”
     
    Stéphane Piat, CEO of CARMAT, added: “The first commercial implant of the Aeson heart is a major milestone in CARMAT’s history. It paves the way for a large number of patients to gradually access our therapy, and is the culmination of many years of work for our teams and our partners. The feedback we are receiving, both within the framework of our clinical trials, notably very recently in the United States, and in our discussions with European hospitals as part of Aeson’s commercialization, makes us very confident that our Aeson artificial heart is a ‘game changer’ and offers unique benefits to patients, compared to all existing therapies. I would like to thank the teams at the Naples hospital for their trust and commitment, and can assure you that our teams are as mobilized as ever to enable other patients, notably in Germany, to benefit from our therapy in the coming weeks.”
     
    Reference
    1 Virtual press conference held by Duke University Hospital on July 15, 2021, following the first implantation of the Aeson heart in the United States within the framework of the EFS (Early Feasibility Study).
    Related Searches
    • Cardiovascular
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Heraeus Medevio Heraeus Medevio
    sfm medical devices GmbH sfm medical devices GmbH
    Simbex Simbex
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Boston Scientific Agrees to Acquire Devoro Medical Boston Scientific Agrees to Acquire Devoro Medical

    Related Buyers Guide Companies

    • Heraeus Medevio

      Heraeus Medevio

      Heraeus is a globally active precious metals and technology Group with firm roots in Germany, headquartered in Hanau near Frankfurt.
      Sara Kruper, Global Marketing Manager 10.17.23

    • sfm medical devices GmbH

      ...
      Albert Busch, Head of Marketing 10.17.23

    • Simbex

      ...
      Greg Lange, Chief Executive Officer 10.12.23


    • Nissha Medical Technologies

      ...
      Amy Jeary, Senior Marketing Manager 10.05.23

    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 09.28.23

    Loading, Please Wait..

    Breaking News
    • Paragonix Reveals Nationwide Organ Procurement Network
    • Covalon Technologies Appoints Interim CEO
    • GE HealthCare's Pneumothorax Algorithm Earns FDA Nod
    • Viz.ai Accelerating Clinical Trial Recruitment for Heart Failure
    • Apyx Welcomes Matthew Hill as Finance Chief
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFT, Seeding the Future Foundation Announce Grants and Awards
    Bioriginal Acquires Softgel Co. to Expand Nutrition Product Line
    Beauty Brand Genaura to Launch Product Line Featuring Gencor’s Levagen+
    Coatings World

    Latest Breaking News From Coatings World

    Advancion Launches Multi-Functional Etheramie for Waterborne Industrial Coatings
    Acme-Hardesty Achieves EcoVadis Silver Medal
    Early Bird Registration for Waterborne Symposium Ends December 2
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Paragonix Reveals Nationwide Organ Procurement Network
    Covalon Technologies Appoints Interim CEO
    GE HealthCare's Pneumothorax Algorithm Earns FDA Nod
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Schreiner MediPharm Introduces New Smart Blister Wallet
    Charles River, GC4K Enter Gene Therapy Mfg. Pact
    RSSL Opens State-of-the-Art Analytical Testing Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WGSN Unveils Top Beauty Trends for 2024 and Beyond
    Huda Kattan Calls Out the Beauty Industry as Sexist
    L’Occitane H1 Sales Up 19%, Driven by Sol de Janeiro and Elemis
    Happi

    Latest Breaking News From Happi

    BASF Launches New Biodegradable, Anti-Redeposition Polymer
    Net Sales Grow 19% For L’Occitane International SA Per FY2024 Interim Results
    Henkel Recognizes Female Researchers with Martha Schwarzkopf Award for Women in Science
    Ink World

    Latest Breaking News From Ink World

    Flexo Ink Market is Anticipated to Reach $7.7B by 2031: TMR
    Acme-Hardesty Earns EcoVadis Silver Medal
    Flint Group, All4Labels Partner with EkoCure Dual Cure Inks
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Flexcon Global adds James Slaughter to team
    Independent II boosts packaging capabilities with Domino
    Avery Dennison announces atma.io updates
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Natureworks Names New CEO
    Gessner Offers Craneglas for the Battery Market
    UAE Baby Care Brand PureBorn Inks Distribution Deal with Laboratoire Naturel
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements Rolls Out Ventana 3D-Printed Interbodies
    Massimo Calafiore Named Orthofix President and CEO
    Exactech Study Shows Fairness, Accuracy of Predict+ for Shoulder Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    LG to Present Innovative Solutions for a Better Life at CES 2024
    BOE Technology Group, Universal Display Sign Long-Term OLED Agreements
    Linxens, PalmSens Partner on Reproducible Gold Electrode

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login